Maria Walenkamp
- Naam
- Drs. M.J.E. Walenkamp
- Telefoon
- +31 71 526 2824
- m.j.e.walenkamp@umail.leidenuniv.nl
- Faculteit Geneeskunde
- Divisie 3
- Willem-Alexander erziekenhuis
- Wit, J.M.; Walenkamp, M.J.; Shamir, R.; Turck, D. & Phillip, M. (2013), Role of Insulin-Like Growth Factors in Growth, Development and Feeding, World Review of Nutrition and Dietetics 106: 60-65.
- Wit, J.M.; Duyvenvoorde, H.A. van; Scheltinga, S.A.; Bruin, S. de; Hafkenscheid, L.; Kant, S.G.; Ruivenkamp, C.A.L.; Gijsbers, A.C.J.; Doorn, J. van; Feigerlova, E.; Noordam, C.; Walenkamp, M.J.; Claahsen-van de Grinten, H.; Stouthart, P.; Bonapart, I.E.; Pereira, A.M.; Gosen, J.; Delemarre-van de Waal, H.A.; Hwa, V.; Breuning, M.H.; Domene, H.M.; Oostdijk, W. & Losekoot, M. (2012), Genetic Analysis of Short Children with Apparent Growth Hormone Insensitivity, Hormone Research in Paediatrics 77(5): 320-333.
- Duyvenvoorde, H.A. van; Doorn, J. van; Koenig, J.; Gauguin, L.; Oostdijk, W.; Wade, J.D.; Karperien, M.; Ruivenkamp, C.A.L.; Losekoot, M.; Setten, P.A. van; Walenkamp, M.J.E.; Noordam, C.; Meyts, P. de & Wit, J.M. (2011), The severe short stature in two siblings with a heterozygous IGF1 mutation is not caused by a dominant negative effect of the putative truncated protein.
- Duyvenvoorde, H.A. van; Setten, P.A. van; Walenkamp, M.J.E.; Doorn, J. van; Koenig, J.; Gauguin, L.; Oostdijk, W.; Ruivenkamp, C.A.L.; Losekoot, M.; Wade, J.D.; Meyts, P. de; Karperien, M.; Noordam, C. & Wit, J.M. (2010), Short Stature Associated with a Novel Heterozygous Mutation in the Insulin-Like Growth Factor 1 Gene, Journal of Clinical Endocrinology and Metabolism 95(11): E363E367.
- Fofanova-Gambetti, O.V.; Hwa, V.; Jorge, A.A.L.; Tonelli, C.A.; Wit, J.M.; Walenkamp, M.J.E.; Domene, H.; Jasper, H.G.; Martinez, A.; Berberoglu, M.; Ocal, G.; Belgorosky, A.; Marino, R.; Miras, M. & Rosenfeld, R.G. (2010), Heterozygous STAT5b Gene Mutations: Impact on Clinical Phenotype., Endocrine Reviews 31(3): -.
- Wu, S.F.; Walenkamp, M.J.; Lankester, A.; Bidlingmaier, M.; Wit, J.M. & Luca, F. de (2010), Growth Hormone and Insulin-Like Growth Factor I Insensitivity of Fibroblasts Isolated from a Patient with an I kappa B alpha Mutation, Journal of Clinical Endocrinology and Metabolism 95(3): 1220-1228.
- Hartmaier RJ, Walenkamp MJE, Richter AS, Wang J, Katzenellenbogen BS, Oesterreich S & Wit JM (2009), A Case of Premature Thelarche With No Central Cause or Genetic Variants Within the Estrogen Receptor Signaling Pathway, Journal of Pediatric Endocrinology and Metabolism 22(8): 751-758.
- Walenkamp MJE & Wit JM (2008), Single gene mutations causing SGA, Best Practice and Research: Clinical Endocrinology and Metabolism 22(3).
- Walenkamp MJE, Keizer-Schrama SMPFD, de Mos M, Kalf ME, van Duyvenvoorde HA, Boot AM, Kant SG, White SJ, Losekoot M, Den Dunnen JT, Karperien M & Wit JM (2008), Successful long-term growth hormone therapy in a girl with haploinsufficiency of the insulin-like growth factor-I receptor due to a terminal 15q26.2-> qter deletion detected by multiplex ligation probe amplification, Journal of Clinical Endocrinology and Metabolism 93(6).
- Walenkamp MJE, Pereira AM, Oostdijk W, Stokvis-Brantsma WH, Pfaeffle RW, Blankenstein O & Wit JM (2008), Height gain with combined growth hormone and gonadotropin-releasing hormone analog therapy in two pubertal siblings with a growth hormone-releasing hormone receptor mutation, Journal of Clinical Endocrinology and Metabolism 93(1).
- Walenkamp MJE, Vidarsdottir S, Pereira AM, Karperien M, van Doorn J, van Duyvenvoorde HA, Breuning MH, Roelfsema F, Kruithof MF, van Dissel J, Janssen R, Wit JM & Romijn JA (2007), Growth hormone secretion and immunological function of a male patient with a homozygous STATSb mutation, European Journal of Endocrinology 156(2).
- Kant SG, Kriek M, Walenkamp MJE, Hansson KBM, van Rhijn A, Clayton-Smith J, Wit JM & Breuning MH (2007), Tall stature and duplication of the insulin-like growth factor I receptor gene.
- Vidarsdottir S, Walenkamp MJE, Pereira AM, Karperien M, van Doorn J, van Duyvenvoorde HA, White S, Breuning MH, Roelfsema F, Kruithof MF, van Dissel J, Janssen R, Wit JM & Romijn JA (2006), Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation, Journal of Clinical Endocrinology and Metabolism 91(9).
- Walenkamp MJE, van der Kamp HJ, Pereira AM, Kant SG, van Duyvenvoorde HA, Kruithof MF, Breuning MH, Romijn JA, Karperien M & Wit JM (2006), A variable degree of intrauterine and postnatal growth retardation in a family with a missense mutation in the insulin-like growth factor I receptor, Journal of Clinical Endocrinology and Metabolism 91(8).
- Walenkamp MJE & Wit JM (2006), Genetic disorders in the growth hormone - Insulin-like growth factor-I axis, Hormone Research 66(5).
- Walenkamp MJE, Karperien M, Pereira AM, Hilhorst-Hofstee Y, van Doorn J, Chen JW, Mohan S, Denley A, Forbes B, van Duyvenvoorde HA, van Thiel SW, Sluimers CA, Bax JJ, de Laat JAPM, Breuning MB, Romijn JA & Wit JM (2005), Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation, Journal of Clinical Endocrinology and Metabolism 90(5).
- Denley A, Wang CXC, McNeil KA, Walenkamp MJE, van Duyvenvoorde H, Wit JM, Wallace JC, Norton RS, Karperien M & Forbes BE (2005), Structural and functional characteristics of the Val(44)Met insulin-like growth factor I missense mutation: Correlation with effects on growth and development, Molecular Endocrinology -Baltimore- 19(3).
- Bakker B, Oostdijk W, Bresters D, Walenkamp MJE, Vossen JM & Wit JM (2004), Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood, Bone Marrow Transplantation 33(10).
- Niewenweg R, Smit ML, Walenkamp MJE & Wit JM (2003), Adult height corrected for shrinking and secular trend, Annals of Human Biology 30(5).